NCT05697861 - Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

March 31, 2038

Study Completion Date

March 31, 2038

Conditions

Transthyretin-Related (ATTR) Familial Amyloid PolyneuropathyTransthyretin-Related (ATTR) Familial Amyloid CardiomyopathyWild-Type Transthyretin Cardiac Amyloidosis

Trial Locations (4)

Unknown

RECRUITING

Clinical Trial Site, Paris

RECRUITING

Clinical Trial Site, Auckland

RECRUITING

Clinical Trial Site, Umeå

RECRUITING

Clinical Trial Site, London